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Summary 
In comparison to B cell stimulation mediated by surface immunoglobulin (Ig) antigen receptor 
ligation, little is known about the intracellular events associated  with T  cell-dependent B cell 
responses.  A model for the efferent phase of T cell-B cell interaction was used to examine the 
capacity of activated T cells to trigger nuclear expression of the trans-acting transcription factor, 
NF-KB, in B cells. Fixed, activated, but not fixed, resting Th2 cells were found to induce increased 
binding activity for a KB site--containing oligonucleotide in a time-dependent manner. This induction 
of NF-KB was eliminated by an antibody directed against a 39-kD cell interaction protein on 
activated T cells as well as by a soluble form of B cell CD40. Of particular relevance to intracellular 
signaling, NF-KB induction was not diminished by prior depletion of B cell protein kinase C 
(PKC) with phorbol myristate acetate.  These results strongly suggest that T  cell-dependent B 
cell stimulation is associated  with NF-KB induction via p39-CD40 interaction and that this is 
brought about by non-PKC dependent signaling, in marked contrast to the previously documented 
requirement for PKC in sIg receptor-mediated stimulation. This suggests that NF-KB responds 
to more than one receptor-mediated intracellular signaling pathway in B cells and may be part 
of a "final common pathway" for B cell stimulation. 
T 
he serological response to monomeric protein antigens 
depends on the cooperative behavior of both T  and B 
cells, encompassing antigen processing and presentation by 
B cells, specific recognition of antigen in the context of MHC 
class II by T cells, and resultant mutual stimulation of both 
interacting parties (for review see reference 1). The develop- 
ment of model systems for T-dependent B cell responses has 
provided the means to dissect these events. It has been shown 
that B cells can be stimulated by T  cells in the absence of 
prior antigen processing, and that T cell stimulation results 
in the appearance of antigen- and MHC-independent B cell 
stimulating activity (1).  The B cell stimulating activity is 
recovered in formaldehyde fixed cell preparations as well as 
in purified membranes obtained from stimulated T cells (1). 
This activity is associated  with the acquisition of a 39-kD 
protein that interacts with B cell CD40 (1-3). Despite prog- 
ress in identifying the ligand-receptor interactions associated 
with T-dependent B cell responses,  relatively little is known 
about the intracellular events triggered by T cells that ulti- 
mately induce B cells to exit the resting state and enter cell 
cycle. 
The cognate binding site for the tram-acting transcription 
factor, NF-KB, is found in the promoters of a number of genes 
of immunological interest, including IgK, IL-2Ro~, and IL-6 
(4). In a polyclonal model for T-independent B cell stimula- 
tion, we have demonstrated that surface Ig (slg) receptor li- 
gation  mediates nuclear expression of NF-KB  in  a  PKC- 
dependent and protein synthesis-independent fashion, sug- 
gesting that NF-KB may function as a "third messenger" that 
transduces cytoplasmic protein kinase signals to nuclear tran- 
scriptional events (5). In the present study we examined the 
regulation of NF-KB during T-dependent B cell stimulation 
in order to discern nuclear events that may be associated with 
T-B cell interaction. 
Materials  and Methods 
Animals.  BALB/cByJ mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME). 
Preparation of Primar  X B Cells.  Spleen  cells from 2--4-mo-old 
naive mice were depleted ofT cells and macrophages by treatment 
with anti-Thy-l.2 antibody plus complement and by plate adher- 
ence, respectively,  as previously described (6). RBC and nonviable 
cells were removed  by sedimentation  over  Lympholyte-M  (Cedarlane, 
Ontario,  Canada). The resulting B ceUs were cultured in RPMI 
1640 medium (BioWhittaker, Inc., Walkersville,  MD) supplemented 
with 5% FCS (Sigma  Chemical Co., St. Louis, MO), 10 mM Hepes 
(Calbiochem-Novabiochem, San Diego, CA), 5  x  10 -s M 2-ME 
(Sigma Chemical Co.),  100 U/ml penicillin, 100 #g/m1  strep- 
tomycin, and 2 mM glutamine. 
Maintenance of Th2 Cells.  The rabbit Ig-specific T cell line 
CDC35  (I-A  a restricted) was propagated biweekly with antigen 
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wk after their last restimulation and were purified before use by 
centrifugation over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). 
Activation and Fixation of Th2 Cells.  T cells were activated by 
overnight  incubation  with  plate  adherent  monoclonal hamster 
anti-mouse CD3 antibody (145-2Cll) and then fixed with 0.5% 
formaldehyde,  as previously  described  (8). 
Proliferation  Assay.  Splenic  B cells (1@ in 0.2 ml) were cultured 
in flat bottomed microtiter wells in quadruplicate  with an equal 
number of fixed, activated (or fixed, resting) T cells, or with other 
reagents, as indicated, for 48 h. Tritium incorporation was assessed 
after exposure to 0.5 #Ci [3H]thymidine  (20 Ci/mmol; New En- 
gland Nuclear, Boston, MA) during the last 6 h of culture, as de- 
scribed (9). 
Preparation of Protein Kinase C (PKC)-depleted B Cells.  Splenic 
B cells were treated with PMA at 100 ng/ml for 20 h (10). PMA- 
treated B cells were washed in complete medium, after which non- 
viable cells were removed by sedimentation over Lympholyte M. 
The wash medium and Lympholyte M contained PMA at 100 ng/ml 
to avoid restoration of PKC. 
Preparation of Nuclear Extracts.  Splenic B cells were cultured 
(107 in 5 ml) in wells of 6-well flat bottomed plates (Costar Corp., 
Cambridge, MA) in the presence or absence of an equal number 
of fixed, activated (or fixed, resting) T cells or with other reagents, 
as indicated.  B cells were lysed in a hypotonic buffer and nuclei 
extracted  in 430 mM NaC1 with protease inhibitors,  as described 
(5). Protein concentrations were determined by the Bradford method 
(11) (Bio-Rad  Laboratories,  Richmond, CA). 
Electrophoretic Mobility shift Assay (EMSA).  Double-stranded 
oligonucleotides  containing the KB sequence (GGGACTTTCC) 
or a mutated KB sequence (TTCACTTTCC) cloned into the BamHI 
site  of PUC13  and PTZ18R plasmids  respectively, were kindly 
provided by Dr. Ranjan Sen (Brandeis University, Waltham, MA). 
The oligonucleotide fragments were end-labeled with c~-[32p]dATP 
and binding reactions and nondenaturating gel electrophoresis were 
carried out as previously described (5). Within a given experiment, 
equal  amounts of nuclear  protein  were  added  to  each binding 
reaction. 
Reagents.  F(ab')2GaMIgM  was  obtained  from Jackson  Im- 
munoResearch Laboratories,  Inc.  (West  Grove,  PA). LPS from 
Salmonella typhimurium and PMA were obtained from Sigma Chem- 
ical Co. MR-1 monoclonal hamster anti-mouse p39 antibody was 
a precious gift from Dr. R.J. Noelle (Dartmouth Medical School, 
Lebanon, NH). Soluble CD40-Ig fusion protein was obtained from 
a cell line kindly provided by Dr. Marilyn Kehry (Castle,  B. E., 
K. Kishimoto, M. L. Brown, and M. R. Kehry, manuscript sub- 
mitted for publication). 
Results 
Induction of  loB-binding Activity in B Cells Stimulated by Fixed, 
Activated  T  Cells (T*).  Cells of the CDC35  Th2  cell line 
were activated by surface-bound anti-CD3 antibody and fixed 
with formaldehyde as described in Materials and Methods. 
T ~ cells failed to exclude trypan blue.  In coculture experi- 
ments,  T ~ stimulated primary  B  cells  to  incorporate  sub- 
stantial amounts of [3H]thymidine, while fixed, nonactivated 
or  resting  T  cells  (T  r)  did  not  (data  not  shown  and  see 
Figure 3 B). 
To determine whether the influence of activated T  cells 
on B cells includes induction of NF-xB, nuclear extracts were 
obtained and analyzed by EMSA using a gB-containing oli- 
Figure  1.  Inductionof~B-bindingactivityinBcellsstimulatedbyfix_ed, 
activated T cells. Nuclear extracts were prepared from primary splenic B 
cells (B) alone or from B cells incubated with either, an equal number 
of fixed, activated  T cells (T  a) for the indicated  times in hours, an equal 
number  of fixed, nonactivated or  resting T  cells (T  r)  for  2  h,  or 
F(ab')2GaMlgM (alg) at 10/zg/ml for 2 h. Nuclear  extracts were also pre- 
pared from T' alone. Nuclear extracts were tested by EMSA, using a ~B 
site-containing  oligonucleotide  probe, as described  in Materials  and Methods. 
The unmarked lane represents ~B probe alone. (~1) Position of specific 
xB-binding activity. One of two comparable experiments is shown. 
gonucleotide, as previously described (5). A detectable (base- 
line) level of nudear xB-binding activity was observed in pri- 
mary B  cells cultured with medium alone (Fig.  1).  When 
T '  were added (1:1),  expression  of nuclear KB-binding ac- 
tivity by B cells increased with time, reaching a plateau at 
4-6 h. This maximum occurred later than that observed with 
slg receptor ligation (5),  and was as great as the induction 
produced by cross-linking anti-Ig antibody (10/zg/ml) at 2 h. 
T r had no effect on B cell xB-binding activity, either at 2 h 
as shown, or at 4 h (data not shown). Further, the measured 
KB-binding activity was not extracted from T '  alone (Fig. 
1). Thus, KB-binding activity is specifically induced in B cells 
byT *. 
The xB-binding activity extracted from T cell-stimulated 
B cells was specifically competed by unlabeled native (wild- 
type) ~B-containing oligonucleotide but not by an oligonu- 
cleotide containing a mutated KB site (data not shown). On 
the basis of the specificity of oligonucleotide binding as well 
as  the  electrophoretic  mobility  of induced  nucleoprotein 
complexes (which parallels that of constitutive and anti-Ig- 
induced nucleoprotein  complexes),  we concluded  that  the 
TLinduced KB-binding activity detected by EMSA represents 
NF-xB  or  a closely related complex. 
Inhibition of  NF-KB Induction by Anti-p39 Antibody and CD40- 
Ig.  To determine whether T  cell p39 plays a role in the in- 
duction of B cell NF-KB, monoclonal hamster anti-p39 anti- 
body was included in the culture with B cells  and TL This 
led to inhibition of TLinduced NF-gB expression as shown 
in Fig.  2 A.  At  the same time,  monodonal hamster anti- 
CD3 antibody, used here as a specificity control, had no effect. 
To evaluate the involvement of interaction with B cell CD40, 
soluble CD40-Ig fusion protein (Castle, B. E., et al., manu- 
script submitted for publication) was included in the culture 
with  B  cells  and  T ~.  This  also  led  to  inhibition  of T ~- 
induced NF-~B expression as shown in Fig. 2 B. This inhibi- 
tion was specific inasmuch as CD40-Ig did not block induc- 
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tibody and by CD40-1g. (,4) Primary splenic B cells (B) were 
incubated  with an equal number of fixed, activated T  cells 
(T  a) or with T ￿9 in the presence of MR1 anti-p39  antibody 
(aP39), or 2Cll anti-CD3 antibody (aCD3), at 10/~g/ml for 
4 h, after which nuclear extracts were prepared. T cells were 
exposed to antibody for 15 min before B cells were added. 
Nuclear extracts  were also obtained  from B cells alone. (B) 
B cells were incubated with an equal number of T~, with T' 
in the presence of soluble CD40-Ig fusion protein (CD40) 
at 3.3/~g/ml, with LPS at 25/zg/ml, or with LPS in the 
presence of CD40-Ig. T cells were exposed to CD40-Ig for 
15 rain before B cells were added. Nuclear extracts were also 
obtained  from B cells alone and from T ~ alone. Nuclear ex- 
tracts were tested by EMSA. The unmarked  lanes represent 
KB probe alone. (.41) Position of specific KB-binding activity. 
In each case, one of two comparable experiments  is shown. 
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Figure  3.  S phase responses of PKC-depleted B cells to fixed, activated 
T cells. Primary splenic B cells were treated with PMA at 100 ng/ml for 
20 h to deplete PKC (light crosshatch), or incubated  for the same length 
of time in medium alone (dark crosshatch). These two B cell populations 
were cultured separately  with either (A) F(ab')xGaMIgM  at  10 #g/ml 
(alg), lipopolysaccharide at 25/zg/ml (LPS), or medium alone (B); or (B) 
an equal number  of fixed, activated T cells (T"), an equal number of fixed, 
nonactivated  or resting  T  cells (T~), or medium alone (B), as indicated, 
for 48 h. In addition,  T ' and T' were incubated  in medium alone. Incor- 
poration of label was assessed after  exposure  of cells to [3H]thymidine 
tion of NF-KB by LPS. These results strongly suggest that 
induction of B cell NF-KB by T a depends on the interaction 
of p39 with its putative receptor, CD40, although the par- 
ticipation  of other molecules has not been ruled out. 
Lack of a Requirement for PKC in NF-gB Induction by T ~ 
Whereas B cell stimulation brought about by sIg ligation 
requires PKC (5, 12), this does not appear to be the case  for 
B cell stimulation induced by T'. As shown in Fig. 3, deple- 
tion of B cell PKC by treatment overnight with PMA some- 
what reduced,.but did not diminate, [3H]thymidine incor- 
poration stimulated by T'. In three experiments, stimulation 
of PMA-treated B cells by T' amounted to 31-59%  of the 
stimulation of untreated B cells. In contrast, PKC depletion 
completely diminated the response of B cells to anti-Ig,  as 
previously suggested (13). The response to LPS, which has 
been reported to be PKC independent (10), was not affected 
by PKC depletion. Thus, unlike (T independent) B cell stim- 
ulation mediated by slg, B cell stimulation induced by acti- 
vated T  cells is not absolutely dependent on PKC (8). 
To evaluate the signaling pathway required for Ta-induced 
NF-KB expression, B cells treated with PMA to deplete PKC 
and untreated B cells were stimulated in various ways, after 
which nuclear extracts were obtained and tested for the pres- 
ence of NF-KB by EMSA. Results are shown in Fig. 4. PMA- 
treated and untreated B cells expressed similar levels of NF-KB 
at baseline. As expected on the basis of previous work from 
this laboratory, PKC depletion completely eliminated NF-KB 
induction produced by anti-Ig (as well as by the direct PKC 
agonist,  PMA) but had little effect on induction of NF-KB 
by LPS (5). When B cells were stimulated by T ~, there was 
no reduction in NF-KB expression resulting from PKC deple- 
tion. In fact, the induction of NF-KB by T ~ was enhanced 
in PMA-treated as opposed to untreated B cells. Thus, in di- 
rect contrast to B cell stimulation mediated by slg, T cells 
induce NF-KB in B cells through a PKC-independent pathway. 
during the last 6 h of culture.  Mean values of quadruplicate  cultures  are 
shown along with lines indicating  the SE of the means. One of two com- 
parable experiments  is shown. 
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fixed, activated  T cells. Primary  splenic B cells were treated with PMA 
at 100 ng/ml for 20 h to deplete PKC (Be), or incubated for the same 
length of time in medium  alone  (B). These two B cell populations  were 
cultured separately  in the same  experiment  with (A) either  an equal  number 
of fixed, activated  T cells (T~), an equal number of fixed, nonactivated 
or resting T cells (Tr), or medium alone, or (B) either F(ab')2GaMIgM 
at 10/~g/ml  (alg), lipopolysaccharide  at 25 #g/ml (LPS), phorbol  myristate 
acetate at 100 ng/ml  (PMA), or medium  alone, as indicated, for 2 h. In 
addition, T  a and T  r were incubated in medium alone (/t). Nuclear ex- 
tracts were prepared and tested  by EMSA. The unmarked  lanes represent 
KB probe alone. (4) Position  of specific  KB-binding  activity.  One of two 
comparable experiments is shown. 
Discussion 
Utilizing a model for the efferent phase of T-B cell inter- 
action, the present results show that T-dependent B cell stim- 
ulation is accompanied by early induction in B cells of the 
trans-acting  transcription factor,  NF-KB. This induction ap- 
pears to be dependent on the availability  of T  cell p39  and 
B cell CD40 and is presumably triggered via the p39/CD40 
ligand/receptor pair.  The present work enlarges  the set of 
surface receptors  whose intracellular signaling results in nu- 
clear expression of NF-gB, which presently includes slg, TCR, 
and IL-2R, and the receptors for IL-1 and TNF-c~ (4, 5, 14-18). 
In primary B ceUs, anti-Ig and T a induce similar levels of 
nuclear NF-~cB, although the time course for T a induction 
is somewhat more prolonged than that for anti-Ig (5). How- 
ever, these two modes of stimulating NF-KB completely di- 
verge when the mechanism underlying NF-gB induction is 
assessed, in that anti-Ig-induced NF-KB requires PKC whereas 
T~-induced  NF-KB does not.  By demonstrating that PKC 
does not play a primary role in T~-mediated  induction of 
NF-KB, the present results provide new insight into the in- 
tracellular signaling mechanism(s) triggered by T ~ and in- 
dicate that T  cells do not simply utilize upstream elements 
of the pathway that has been defined for slg ligation. This 
accords well with the failure to demonstrate PKC activation 
in B cells stimulated by plasma  membranes obtained from 
activated T cells recently observed by Dr. R. J. Noelle (per- 
sonal communication). Although the observation that T cells 
stimulate cAMP in B ceils (19) might suggest that NF-KB 
induction results from PKA-mediated phosphorylation of IgB 
(20),  this target for PKA is not universally accepted  (21). 
Whereas PKC depletion did not impair induction of NF-gB 
by T ~ at all, S phase entry was reduced somewhat. Notwith- 
standing the fact that both responses  still proceeded in the 
absence of PKC, this difference emphasizes that no single tran- 
scription factor is likely to play an overarching role in deter- 
mining S phase entry. 
Although the discrete mechanism responsible for T-depen- 
dent induction of NF-gB remains to be elucidated, the present 
work clearly demonstrates that T cells (presumably via B cell 
CD40) and sIg utilizes different intracellular signaling path- 
ways to stimulate nuclear NF-KB expression.  Thus, in the 
same cell type two separate receptors  appear  to induce the 
same transcription factor yet do so via separate mechanisms. 
This suggests the possibility that NF-gB may be one of an 
unknown number of transcription factors  that take part in 
a final common pathway for B ceU stimulation, responsive 
to divergent receptorAignaling pathways, but always involved 
in regulating the nuclear transcriptional events that are as- 
sociated  with growth control. 
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